Tommie Reerink

Stock Analyst at Goldman Sachs

(2.00)
# 2,763
Out of 4,829 analysts
3
Total ratings
66.67%
Success rate
1.16%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $6.47
Upside: +70.02%